PharmaJet partner Zydus Cadila announces Emergency Use Authorization approval for world’s first plasmid DNA COVID-19 vaccine

GOLDEN, Colo. — August 23, 2021 - PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Zydus Cadila has received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the world’s first Plasmid DNA Vaccine for COVID-19. The vaccine, ZyCoV-D, is exclusively administered using the PharmaJet Tropis® Needle-free Injection System.